ProfileGDS4718 / 222505_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 65% 73% 69% 62% 83% 80% 72% 63% 71% 74% 61% 82% 75% 80% 71% 75% 79% 80% 62% 70% 71% 70% 68% 67% 78% 71% 77% 71% 80% 77% 86% 62% 71% 77% 82% 82% 72% 69% 73% 70% 78% 79% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4787265
GSM549102patient 115, normal, homogenized [OPG study]6.4817565
GSM549104patient 119, normal, homogenized [OPG study]7.2022373
GSM549108patient 138, normal, homogenized [OPG study]6.7364769
GSM549119patient 077, normal, homogenized [OPG study]6.2719362
GSM549133patient 032, cancer, homogenized [OPG study]8.326483
GSM549139patient 042, cancer, homogenized [OPG study]7.8783880
GSM549099patient 107, normal, homogenized [OPG study]7.0255272
GSM549109patient 139, normal, homogenized [OPG study]6.3081663
GSM549110patient 046, normal, homogenized [OPG study]6.91271
GSM549114patient 063, normal, homogenized [OPG study]7.2472374
GSM549122patient 082, normal, homogenized [OPG study]6.1802461
GSM549134patient 033, cancer, homogenized [OPG study]8.1801182
GSM549136patient 036, cancer, homogenized [OPG study]7.4388875
GSM549140patient 044, cancer, homogenized [OPG study]7.9279580
GSM549111patient 047, normal, homogenized [OPG study]7.0091171
GSM549113patient 057, normal, homogenized [OPG study]7.4392175
GSM549132patient 031, cancer, homogenized [OPG study]7.7339579
GSM549137patient 038, cancer, homogenized [OPG study]7.8908780
GSM549142patient 047, cancer, homogenized [OPG study]6.3275162
GSM549100patient 110, normal, homogenized [OPG study]6.8199870
GSM549107patient 135, normal, homogenized [OPG study]6.9331171
GSM549115patient 068, normal, homogenized [OPG study]6.9089570
GSM549116patient 072, normal, homogenized [OPG study]6.7310668
GSM549120patient 078, normal, homogenized [OPG study]6.6002267
GSM549131patient 030, cancer, homogenized [OPG study]7.8087278
GSM549118patient 074, normal, homogenized [OPG study]6.9571971
GSM549129patient 027, cancer, homogenized [OPG study]7.5377277
GSM549123patient 088, normal, homogenized [OPG study]6.9873171
GSM549124patient 006, cancer, homogenized [OPG study]7.7421680
GSM549126patient 015, cancer, homogenized [OPG study]7.5771577
GSM549128patient 025, cancer, homogenized [OPG study]8.6810786
GSM549103patient 117, normal, homogenized [OPG study]6.2905662
GSM549117patient 073, normal, homogenized [OPG study]6.8958371
GSM549138patient 041, cancer, homogenized [OPG study]7.6222177
GSM549141patient 045, cancer, homogenized [OPG study]8.2357882
GSM549130patient 028, cancer, homogenized [OPG study]8.0065682
GSM549101patient 111, normal, homogenized [OPG study]7.0668672
GSM549105patient 128, normal, homogenized [OPG study]6.7910669
GSM549106patient 134, normal, homogenized [OPG study]7.2980973
GSM549112patient 048, normal, homogenized [OPG study]6.8501870
GSM549125patient 011, cancer, homogenized [OPG study]7.6427778
GSM549127patient 024, cancer, homogenized [OPG study]7.774279
GSM549135patient 035, cancer, homogenized [OPG study]8.6149885